DOCSLIB.ORG

Short-Chain Polyfluoroalkyl Substances (PFAS)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Short-Chain Polyfluoroalkyl Substances (PFAS) Short-chain Polyfluoroalkyl Substances (PFAS) A literature review of information on human health effects and environmental fate and effect aspects of short-chain PFAS Environmental project No. 1707, 2015 Title: Editing: Short-chain Polyfluoroalkyl Substances (PFAS) Jesper Kjølholt 1 Allan Astrup Jensen 2 Marlies Warming 1 1: COWI A/S 2: NIPSECT Published by: The Danish Environmental Protection Agency Strandgade 29 1401 Copenhagen K Denmark www.mst.dk/english Year: ISBN no. 2015 978-87-93352-15-5 Disclaimer: When the occasion arises, the Danish Environmental Protection Agency will publish reports and papers concerning re- search and development projects within the environmental sector, financed by study grants provided by the Danish Envi- ronmental Protection Agency. It should be noted that such publications do not necessarily reflect the position or opinion of the Danish Environmental Protection Agency. However, publication does indicate that, in the opinion of the Danish Environmental Protection Agency, the content represents an important contribution to the debate surrounding Danish environmental policy. Sources must be acknowledged. 2 Contents Preface ...................................................................................................................... 5 Summary and Conclusion .......................................................................................... 7 Sammendrag og konklusion ..................................................................................... 11 1. Introduction ..................................................................................................... 15 1.1 Background and scope .......................................................................................................... 15 1.2 Objective ................................................................................................................................ 15 2. Chemistry and uses ........................................................................................... 17 2.1 Background about polyfluoroalkylated substances (PFAS) ................................................ 17 2.2 Short-chain alternatives to C8-polyfluoroalkylated substances .........................................18 2.3 Developments in industry ................................................................................................... 20 2.4 Recent uses of short-chain alternatives ............................................................................... 21 2.4.1 Impregnation .......................................................................................................... 21 2.4.2 Fire-fighting foams................................................................................................. 21 2.4.3 Metal plating .......................................................................................................... 21 2.4.4 Oil production ........................................................................................................ 21 2.4.5 Food packaging ...................................................................................................... 21 2.5 Substances included in this study ....................................................................................... 22 3. Human health effects ........................................................................................ 23 3.1 General aspects of toxicokinetics and metabolism ............................................................. 23 3.1.1 Uptake and distribution ........................................................................................ 23 3.1.2 Levels in human blood .......................................................................................... 24 3.1.3 Metabolism/biotransformation ............................................................................ 26 3.1.4 Excretion/elimination from the body .................................................................. 27 3.1.5 Blood serum elimination half-lives ...................................................................... 27 3.1.6 Fetal and lactational transfer ................................................................................ 28 3.2 Toxicological mechanisms ................................................................................................... 28 3.2.1 Peroxisome proliferation ...................................................................................... 28 3.2.2 Effects on cell membranes .................................................................................... 29 3.2.3 Effect on lipids ....................................................................................................... 29 3.2.4 Cytotoxicity ............................................................................................................ 29 3.2.5 Neurotoxicity ......................................................................................................... 30 3.2.6 Endocrine disruption ............................................................................................ 30 3.3 Toxic effects of single PFAS ................................................................................................. 30 3.3.1 Perfluoroalkane sulfonic acids/sulfonates (PFSA) ............................................... 31 3.3.2 Perfluoroalkanoic acids/perfluoroalkanoates, perfluorocarboxylic acid/perfluorocarboxylates (PFCA)...................................................................... 36 3.3.3 Perfluoroalkyl halogenides ................................................................................... 39 3.3.4 Perfluoroalkyl phosphor compounds ................................................................... 39 3.3.5 Fluorotelomers and derivatives ............................................................................ 40 3.4 Occurrence and exposure in relation to humans ................................................................ 45 3.4.1 Occurrence in products ......................................................................................... 45 3.4.2 PFAS in indoor air and workplace air .................................................................. 46 4. Environmental fate and effects .........................................................................49 4.1 Environmental behaviour and fate ..................................................................................... 49 4.1.1 Physico-chemical properties of environmental relevance ................................... 49 4.1.2 Abiotic transformation and degradation .............................................................. 50 4.1.3 Biotransformation and degradation ..................................................................... 50 4.1.4 Bioaccumulation .................................................................................................... 51 4.1.5 Sorption, mobility and distribution ....................................................................... 51 4.1.6 Long-range atmospheric and marine transport .................................................. 52 4.2 Environmental effects .......................................................................................................... 52 4.2.1 Toxicity to aquatic organisms ............................................................................... 53 4.2.2 Toxicity to terrestrial organisms........................................................................... 59 4.3 Environmental fate and effects of single PFAS .................................................................... 61 4.3.1 Perfluoroalkane sulfonic acids/sulfonates (PFSA) ............................................... 61 4.3.2 Perfluoroalkanoic acids/perfluoroalkanoates, perfluorocarboxylic acids and perfluorocarboxylates (PFCA) .............................................................................. 62 4.3.3 Perfluoroalkyl halogenides ................................................................................... 63 4.3.4 Perfluoroalkyl phosphor compounds ................................................................... 63 4.3.5 Fluorotelomers ...................................................................................................... 63 4.4 PBT assessment.................................................................................................................... 64 4.5 Environmental occurrence and exposure ........................................................................... 65 4.5.1 Aquatic environment ............................................................................................ 65 4.5.2 Terrestrial environment ........................................................................................ 70 4.5.3 Biota ........................................................................................................................ 71 4.5.4 Atmospheric environment .................................................................................... 73 5. Summary and conclusions ................................................................................ 75 5.1 Human health effects and exposure .....................................................................................75 5.1.1 Human health effects .............................................................................................75 5.1.2 Exposure of humans ............................................................................................. 76 5.2 Environmental fate and effects ..........................................................................................
Load more

Recommended publications
  • Analytical Standards for Human Exposure Analysis
    ENVIRONMENTAL STANDARDS Cambridge Isotope Laboratories, Inc. isotope.com Analytical Standards for Human Exposure Analysis Human Personal Care Industrial Products Pollution Dermal Inhalation Ingestion Food Tobacco Products Drinking Water Pharmaceuticals Cambridge Isotope Laboratories, Inc. North America: 1.800.322.1174 [email protected] | International: +1.978.749.8000 [email protected] | fax: 1.978.749.2768 | isotope.com Cambridge Isotope Laboratories, Inc. | Analytical Standards for Human Exposure Analysis Analytical Standards for Human Exposure Analysis Exposomics is the study of the exposome and is a field that has been gaining attention as researchers focus not only on identifying contaminants present in the environment, but their effects on humans. The exposome encompasses an individual’s lifetime exposure to internal and external stresses, including environmental, dietary, and metabolic factors, to name a few. Cambridge Isotope Laboratories, Inc. (CIL) has and continues to produce standards that are used in many leading biomonitoring research projects, such as the US Centers for Disease Control and Prevention (CDC) “National Health and Nutrition Examination Survey (NHANES)” and the Japan National Institute for Environmental Studies (NIES) “Japan Environment and Children’s Study (JECS).” The CDC’s NHANES program is focused on assessing the health and nutritional status of both children and adults in the United States. There are several studies involved in this program, which is notable in that both interviews and physical examinations are factored in when compiling data. The first NHANES study was conducted from 1971-1975 and subsequent studies are continuing to this day. Additional information about the NHANES program can be found at www.cdc.gov/nchs/nhanes/index.htm.
    [Show full text]
  • Some ABCA3 Mutations Elevate ER Stress and Initiate Apoptosis of Lung Epithelial Cells
    Some ABCA3 mutations elevate ER stress and initiate apoptosis of lung epithelial cells Nina Weichert Aus der Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital der Ludwig-Maximilians-Universität München Direktor: Prof. Dr. med. Dr. sci. nat. Christoph Klein Some ABCA3 mutations elevate ER stress and initiate apoptosis of lung epithelial cells Dissertation zum Erwerb des Doktorgrades der Humanmedizin an der Medizinischen Fakultät der Ludwig-Maximilians-Universität zu München Vorgelegt von Nina Weichert aus Heidelberg 2011 Mit Genehmigung der Medizinischen Fakultät der Universität München 1. Berichterstatter: Prof. Dr. Matthias Griese 2. Berichterstatter: Prof. Dr. Dennis Nowak Mitberichterstatter: Priv. Doz. Dr. Angela Abicht Prof. Dr. Michael Schleicher Mitbetreuung durch den promovierten Mitarbeiter: Dr. Suncana Kern Dekan: Herr Prof. Dr. med. Dr. h. c. Maximilian Reiser, FACR, FRCR Tag der mündlichen Prüfung: 24.11.2011 Table of Contents 1.Abstract ................................................................................................................... 1 2.Zusammenfassung................................................................................................. 2 3.Intoduction .............................................................................................................. 3 3.1 Pediatric interstitial lung disease ............................................................................... 3 3.1.1 Epidemiology of pILD..............................................................................................
    [Show full text]
  • Surface Activity of Pulmonary Surfactant Protein B
    Surface Activity of Pulmonary Surfactant Protein B From Biophysical Properties to Clinical Application Rob Diemel Surface activity of pulmonary surfactant protein B From biophysical properties to clinical application Robert V. Diemel Ph.D. thesis, with summary in Dutch Utrecht University, the Netherlands January 2002 The studies described in this thesis were performed at the Department of Anaesthesiology and Critical Care Medicine, The Leopold-Franzens-University of Innsbruck, Austria, and at the Department of Biochemistry and Cell Biology, Faculty of Veterinary Medicine, Utrecht University, the Netherlands. Copyright © 2002 by R.V. Diemel. All rights reserved. No part of this thesis may be reproduced or transmitted in any form or by any means, without written permission from the author. Surface Activity of Pulmonary Surfactant Protein B From Biophysical Properties to Clinical Application Oppervlakte-Activiteit van Long Surfactant Eiwit B Van Biofysische Eigenschappen tot Klinische Toepassing (met een samenvatting in het Nederlands) Proefschrift ter verkrijging van de graad van doctor aan de Universiteit Utrecht op gezag van de Rector Magnificus, Prof. Dr. W.H. Gispen, ingevolge het besluit van het College voor Promoties in het openbaar te verdedigen op 10 januari 2002 des middags te 14.30 uur door Robert Victor Diemel geboren op 29 augustus 1972, te Driebergen-Rijsenburg Promotores: Prof. Dr. L.M.G. van Golde Hoofdafdeling Biochemie & Celbiologie Faculteit der Diergeneeskunde, Universiteit Utrecht Prof. Dr. H.P. Haagsman Hoofdafdeling Voedingsmiddelen van Dierlijke Oorsprong Faculteit der Diergeneeskunde, Universiteit Utrecht Co-promotores: Dr. J.J. Batenburg Hoofdafdeling Biochemie & Celbiologie Faculteit der Diergeneeskunde, Universiteit Utrecht Prof. Dr. G. Putz Universitätsklinik für Anästhesie und allgemeine Intensivmedizin Leopold-Franzens Universität Innsbruck, Österreich The work described in this thesis was financially supported by the Fonds zur Förderung der Wissenschaftlichen Forschung (FWF) (P11527-MED), Austria.
    [Show full text]
  • Single-Cell Transcriptomics Identifies Dysregulated Metabolic Programs of Aging Alveolar Progenitor Cells in Lung Fibrosis
    bioRxiv preprint doi: https://doi.org/10.1101/2020.07.30.227892; this version posted July 30, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Single-Cell Transcriptomics Identifies Dysregulated Metabolic Programs of Aging Alveolar Progenitor Cells in Lung Fibrosis Jiurong Liang1,6, Guanling Huang1,6, Xue Liu1, Forough Taghavifar1, Ningshan Liu1, Changfu Yao1, Nan Deng2, Yizhou Wang3, Ankita Burman1, Ting Xie1, Simon Rowan1, 5 Peter Chen1, Cory Hogaboam1, Barry Stripp1, S. Samuel Weigt5, John Belperio5, William C. Parks1,4, Paul W. Noble1, and Dianhua Jiang1,4 1Department of Medicine and Women’s Guild Lung Institute, 2Samuel Oschin Comprehensive Cancer Institute, 3Genomics Core, 4Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. 5Department of Medicine 10 University of California, Los Angeles (UCLA), Los Angeles, CA 90048, USA. 6These authors contributed equally. Correspondence and requests for materials should be addressed to P.W.N. ([email protected]), D.J. ([email protected]). Running title: Metabolic defect of aging alveolar progenitor 15 One sentence summary: Metabolic defects of alveolar progenitors in aging and during lung injury impair their renewal. Data availability: The single cell RNA-seq are deposited Funding statement: This work was supported by NIH grants R35-HL150829, R01- HL060539, R01-AI052201, R01-HL077291, and R01-HL122068, and P01-HL108793. 20 Conflict of interest: The authors declare that there is no conflict of interest. Ethics approval statement: All mouse experimens were under the guidance of the IACUC008529 in accordance with institutional and regulatory guidelines.
    [Show full text]
  • Priority Pollutant, Endocrine Disruptor, and Chemical Contaminant Standards Solutions for a Greener World Introduction
    Priority Pollutant, Endocrine Disruptor, and Chemical Contaminant Standards Solutions for a Greener World Introduction Priority Pollutant, Endocrine Disruptor, and Chemical Contaminant Standards isotope.com Pharmaceutical and Personal Care Product Halogenated and Substituted Benzene Standards and Phenol Standards Concern about environmental and human exposure to Many industrial and consumer products are composed of pharmaceuticals and personal care products (PPCPs) has grown chemicals that contain halogenated or substituted benzene significantly. This classification encompasses a broad range of or phenol functional groups. Resistant to decomposition and chemicals, ranging from antibiotics to hormones to pesticides. metabolism, these chemicals may persist even after the parent One common theme among these groups is the need for molecule has undergone partial decomposition, or they may high-quality isotopically labeled standards to strengthen the exist as a product or an industrial byproduct. The increased analysis of PPCPs in difficult matrices such as sewage sludge use of brominated compounds is expected to lead to more and wastewater. CIL, with guidance from leading laboratories brominated benzenes and phenols in the environment, and around the world, works diligently to produce representative the continued presence of chlorinated compounds ensures standards for the analysis of PPCPs. that chlorinated benzenes and phenols will be found in the environment for years to come. Food and Drinking Water Analysis Standards Bisphenol Standards Increased attention to possible contamination of food and Bisphenol A (BPA) is a synthetic compound that has long been water has caused analysts to broaden the scope of trace food used in the production of polycarbonate plastics and epoxy and water testing by IDMS.
    [Show full text]
  • PFOA) and Suggested As PFCA Precursor Compounds (7, 8)
    within a few days. Fluorotelomer alcohols (FTOHs) have been Formation of C7F15COOH (PFOA) and suggested as PFCA precursor compounds (7, 8). FTOHs are linear fluorinated alcohols with the formula CnF2n+1CH2CH2- Other Perfluorocarboxylic Acids OH (n ) 2, 4, 6, ...). The telomerization process results in during the Atmospheric Oxidation of even-numbered linear chains, and the alcohols are named according to the number of fluorinated and hydrogenated 8:2 Fluorotelomer Alcohol carbons, e.g., C8F17CH2CH2OH is 8:2 fluorotelomer alcohol (8:2 FTOH). Global production of FTOHs is 12 106 kg year-1, × T . J . W A L L I N G T O N , * , † M . D . H U R L E Y , † and sales are approximately $700 million annually (9). J . X I A , ‡ D . J . W U E B B L E S , ‡ S . S I L L M A N , § Fluorotelomer alcohols are volatile, have been observed in A . I T O , § J . E . P E N N E R , § D . A . E L L I S , | the North American atmosphere in significant concentrations -3 J . M A R T I N , | S . A . M A B U R Y , | (17-135 pg m ) (10, 11), and have an atmospheric lifetime O . J . N I E L S E N , ⊥ A N D (10-20 days) sufficient for widespread hemispheric distribu- M . P . S U L B A E K A N D E R S E N ⊥ tion (7, 12). C8F17CH2CH2OH (8:2 FTOH) is the most important Ford Motor Company, SRL-3083, P.O. Box 2053, Dearborn, FTOH and is the subject of the present study.
    [Show full text]
  • Recommendation on Perfluorinated Compound Treatment Options for Drinking Water
    Recommendation on Perfluorinated Compound Treatment Options for Drinking Water New Jersey Drinking Water Quality Institute Treatment Subcommittee June 2015 Laura Cummings, P.E., Chair Anthony Matarazzo Norman Nelson, P.E. Fred Sickels Carol T. Storms Background At the request of the Commissioner of the New Jersey Department of Environmental Protection the Drinking Water Quality Institute (DWQI) is working to develop recommended Maximum Contaminant Levels (MCL) for three long-chain perfluorinated compounds (PFC): Perfluorononanoic acid (PFNA), Perfluorooctanoic acid (PFOA) and Perfluorooctanesulfonic acid (PFOS). The Treatment Subcommittee of the Drinking Water Quality Institute is responsible for identifying available treatment technologies or methods for removal of hazardous contaminants from drinking water. The subcommittee has met several times over the last year beginning in July 2014 to discuss and investigate best available treatment options for the long-chain (8 – 9 carbon) PFCs identified above. The subcommittee decided to research and report on treatment options for all three compounds, as the treatment options are not expected to differ from compound to compound due to their similar properties (e.g. persistence, water solubility, similar structure, strong carbon-fluorine bonds, and high polarity). This approach contrasts with the other two subcommittees which will address the three compounds separately. The subcommittee has gathered and reviewed data from several sources in order to identify widely-accepted and well-performing strategies for removal of long-chain PFCs, including use of alternate sources. This report is intended to present the subcommittee’s findings. At this time, there are no Federal drinking water standards for PFNA, PFOA or PFOS; however in 2009 the United State Environmental Protection Agency (USEPA, 2009) established a Provisional Health Advisory (PHA) level of 0.4 µg/L for PFOA and 0.2 µg/L PHA for PFOS for short-term exposure.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2003/0082511 A1 Brown Et Al
    US 20030082511A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2003/0082511 A1 Brown et al. (43) Pub. Date: May 1, 2003 (54) IDENTIFICATION OF MODULATORY Publication Classification MOLECULES USING INDUCIBLE PROMOTERS (51) Int. Cl." ............................... C12O 1/00; C12O 1/68 (52) U.S. Cl. ..................................................... 435/4; 435/6 (76) Inventors: Steven J. Brown, San Diego, CA (US); Damien J. Dunnington, San Diego, CA (US); Imran Clark, San Diego, CA (57) ABSTRACT (US) Correspondence Address: Methods for identifying an ion channel modulator, a target David B. Waller & Associates membrane receptor modulator molecule, and other modula 5677 Oberlin Drive tory molecules are disclosed, as well as cells and vectors for Suit 214 use in those methods. A polynucleotide encoding target is San Diego, CA 92121 (US) provided in a cell under control of an inducible promoter, and candidate modulatory molecules are contacted with the (21) Appl. No.: 09/965,201 cell after induction of the promoter to ascertain whether a change in a measurable physiological parameter occurs as a (22) Filed: Sep. 25, 2001 result of the candidate modulatory molecule. Patent Application Publication May 1, 2003 Sheet 1 of 8 US 2003/0082511 A1 KCNC1 cDNA F.G. 1 Patent Application Publication May 1, 2003 Sheet 2 of 8 US 2003/0082511 A1 49 - -9 G C EH H EH N t R M h so as se W M M MP N FIG.2 Patent Application Publication May 1, 2003 Sheet 3 of 8 US 2003/0082511 A1 FG. 3 Patent Application Publication May 1, 2003 Sheet 4 of 8 US 2003/0082511 A1 KCNC1 ITREXCHO KC 150 mM KC 2000000 so 100 mM induced Uninduced Steady state O 100 200 300 400 500 600 700 Time (seconds) FIG.
    [Show full text]
  • Human Lectins, Their Carbohydrate Affinities and Where to Find Them
    biomolecules Review Human Lectins, Their Carbohydrate Affinities and Where to Review HumanFind Them Lectins, Their Carbohydrate Affinities and Where to FindCláudia ThemD. Raposo 1,*, André B. Canelas 2 and M. Teresa Barros 1 1, 2 1 Cláudia D. Raposo * , Andr1 é LAQVB. Canelas‐Requimte,and Department M. Teresa of Chemistry, Barros NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2829‐516 Caparica, Portugal; [email protected] 12 GlanbiaLAQV-Requimte,‐AgriChemWhey, Department Lisheen of Chemistry, Mine, Killoran, NOVA Moyne, School E41 of ScienceR622 Co. and Tipperary, Technology, Ireland; canelas‐ [email protected] NOVA de Lisboa, 2829-516 Caparica, Portugal; [email protected] 2* Correspondence:Glanbia-AgriChemWhey, [email protected]; Lisheen Mine, Tel.: Killoran, +351‐212948550 Moyne, E41 R622 Tipperary, Ireland; [email protected] * Correspondence: [email protected]; Tel.: +351-212948550 Abstract: Lectins are a class of proteins responsible for several biological roles such as cell‐cell in‐ Abstract:teractions,Lectins signaling are pathways, a class of and proteins several responsible innate immune for several responses biological against roles pathogens. such as Since cell-cell lec‐ interactions,tins are able signalingto bind to pathways, carbohydrates, and several they can innate be a immuneviable target responses for targeted against drug pathogens. delivery Since sys‐ lectinstems. In are fact, able several to bind lectins to carbohydrates, were approved they by canFood be and a viable Drug targetAdministration for targeted for drugthat purpose. delivery systems.Information In fact, about several specific lectins carbohydrate were approved recognition by Food by andlectin Drug receptors Administration was gathered for that herein, purpose. plus Informationthe specific organs about specific where those carbohydrate lectins can recognition be found by within lectin the receptors human was body.
    [Show full text]
  • Biotransformation of AFFF Component 6:2 Fluorotelomer Thioether Amido
    Biotransformation of AFFF Component 6:2 Fluorotelomer Thioether Amido Sulfonate Generates 6:2 Fluorotelomer Thioether Carboxylate under Sulfate-Reducing Conditions Shan Yi†, Katie C. Harding-Marjanovic‡, Erika F. Houtz§, Ying Gao∥, Jennifer E. Lawrence†, Rita V. Nichiporuk⊥, Anthony T. Iavarone⊥, Wei-Qin Zhuang#, Martin Hansen@, Jennifer A. Field∇, David L. Sedlak†, and Lisa Alvarez- Cohen*†● † Department of Civil and Environmental Engineering, University of California, Berkeley, California 94720, United States ‡ Exponent, Pasadena, California 91106, United States § Arcadis, San Francisco, California 94104, United States ∥ Institute of Desertification Studies, Chinese Academy of Forestry, Beijing 100091, China ⊥ The California Institute for Quantitative Biosciences (QB3), University of California, Berkeley, California 94720, United States # Department of Civil and Environmental Engineering, University of Auckland, Auckland 1142, New Zealand @ Department of Environmental Science, Aarhus University, 4000 Roskilde, Denmark ∇ Department of Molecular and Environmental Toxicology, Oregon State University, Corvallis, Oregon 97331, United States ● Earth and Environmental Sciences Division, Lawrence Berkeley National Laboratory, Cyclotron Road, Berkeley, California 94720, United States *Department of Civil and Environmental Engineering, 726 Davis Hall, University of California, Berkeley, CA 94720-1710. Phone: (510) 643-5969. Fax: (510) 642-7483. E-mail: [email protected]. Abstract The fate of per- and polyfluoroalkyl substances (PFASs) in aqueous film- forming foams (AFFFs) under anaerobic conditions has not been well characterized, leaving major gaps in our understanding of PFAS fate and transformation at contaminated sites. In this study, the biotransformation of 6:2 fluorotelomer thioether amido sulfonate (6:2 FtTAoS), a component of several AFFF formulations, was investigated under sulfate-reducing conditions in microcosms inoculated with either pristine or AFFF-impacted solids.
    [Show full text]
  • UNITED NATIONS Stockholm Convention on Persistent Organic Pollutants Technical Paper on the Identification and Assessment Of
    UNITED NATIONS SC UNEP/POPS/POPRC.8/INF/17 Distr.: General 15 August 2012 English only Stockholm Convention on Persistent Organic Pollutants Persistent Organic Pollutants Review Committee Eighth meeting Geneva, 15–19 October 2012 Item 5 (g) of the provisional agenda* Technical work: assessment of alternatives to perfluorooctane sulfonic acid in open applications Technical paper on the identification and assessment of alternatives to the use of perfluorooctane sulfonic acid in open applications Note by the Secretariat 1. In paragraph 6 of decision SC-5/5, the Conference of the Parties to the Stockholm Convention requested the Secretariat, subject to the availability of resources, to commission a technical paper on the identification and assessment of alternatives to the use of perfluorooctane sulfonic acid in open applications for consideration by the Persistent Organic Pollutants Review Committee at its eighth meeting. 2. That technical paper has been prepared, with financial support provided by the Government of Norway, on the basis of the terms of reference and an outline developed by the Committee at its seventh meeting. It is set out in the annex to the present note, where it is presented without formal editing. * UNEP/POPS/POPRC.8/1. K1282361 110912 UNEP/POPS/POPRC.8/INF/17 Annex Technical paper on the identification and assessment of alternatives to the use of perfluorooctane sulfonic acid in open applications 2 UNEP/POPS/POPRC.8/INF/17 Table of contents Executive summary.........................................................................................................................................................
    [Show full text]
  • In Vitro and in Vivo Estrogenic Effects of Fluorotelomer Alcohols in Medaka (Oryzias Latipes)
    Interdisciplinary Studies on Environmental Chemistry—Biological Responses to Chemical Pollutants, Eds., Y. Murakami, K. Nakayama, S.-I. Kitamura, H. Iwata and S. Tanabe, pp. 291–301. © by TERRAPUB, 2008. In vitro and in vivo Estrogenic Effects of Fluorotelomer Alcohols in Medaka (Oryzias latipes) Hiroshi ISHIBASHI1, Ryoko YAMAUCHI1, Munekazu MATSUOKA1, Joon-Woo KIM1, Masashi HIRANO1, Akemi YAMAGUCHI2, Nobuaki TOMINAGA2 and Koji ARIZONO1 1Faculty of Environmental and Symbiotic Sciences, Prefectural University of Kumamoto, 3-1-100 Tsukide, Kumamoto 862-8502, Japan 2Department of Chemical and Biological Engineering, Ariake National College of Technology, 150 Higashihagio-machi, Omuta, Fukuoka 836-8585, Japan (Received 15 May 2008; accepted 31 July 2008) Abstract—The present study demonstrates the estrogenic effects of two fluorotelomer alcohols, such as 1H,1H,2H,2H-perfluorooctan-1-ol (6:2 FTOH) and 1H,1H,2H,2H-perfluorodecan-1-ol (8:2 FTOH), in medaka (Oryzias latipes). An in vitro yeast two-hybrid assay indicated a significant, dose- dependent interaction between medaka estrogen receptor α (ERα) and coactivator TIF2 upon treatment with 6:2 FTOH or 8:2 FTOH. In contrast, no interaction with the ERα was observed upon treatment with perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA), perfluorononanoic acid (PFNA), perfluorododecanoic acid (PFDA) or perfluoroundecanoic acid (PFUnDA). Expression analysis of hepatic vitellogenin (VTG) protein showed estrogenic potentials with, 6:2 FTOH and 8:2 FTOH, indicative of the induction of VTG synthesis in the livers of male medaka. We also investigated mRNA expression levels of two ER subtypes and two VTGs in the livers of male medaka following exposure to FTOHs. Quantitative real-time PCR analyses revealed that hepatic ERα, VTG I, and VTG II mRNA responded rapidly to FTOHs such as 6:2 FTOH and 8:2 FTOH after 8-h exposure, whereas no effects of these compounds on ERβ mRNA transcription were observed.
    [Show full text]